Streetbeat News

Price Targets

HUM

RBC Capital analyst Ben Hendrix maintains an Outperform rating on Humana (NYSE:HUM) and raises the price target from $594 to $599.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:50 pm

HUN

RBC Capital analyst Arun Viswanathan has maintained a 'Sector Perform' rating on Huntsman (NYSE:HUN) but lowered the price target from $26 to $22.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:45 pm

LPX

RBC Capital analyst Paul Quinn has maintained an 'Outperform' rating on Louisiana-Pacific (NYSE:LPX), but lowered the price target from $75 to $72.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:43 pm

EQR

RBC Capital analyst Brad Heffern maintains an 'Outperform' rating on Equity Residential (NYSE:EQR) but has lowered the price target from $68 to $65.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:41 pm

DD

RBC Capital analyst Arun Viswanathan maintains an 'Outperform' rating on DuPont de Nemours (NYSE:DD), but has lowered the price target from $90 to $85.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:36 pm

CVS

RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on CVS Health (NYSE:CVS), but lowered the price target from $91 to $86.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:35 pm

DXC

RBC Capital analyst Daniel Perlin has maintained a 'Sector Perform' rating on DXC Technology (NYSE:DXC) but lowered the price target from $29 to $24.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:33 pm

BLDR

RBC Capital analyst Mike Dahl has maintained an 'Outperform' rating on Builders FirstSource (NYSE:BLDR), but lowered the price target from $188 to $152.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:31 pm

EAT

RBC Capital analyst Christopher Carril maintains a 'Sector Perform' rating on Brinker International (NYSE:EAT) and raises the price target from $38 to $40.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:29 pm

AMGN

RBC Capital analyst Gregory Renza maintains a 'Sector Perform' rating on Amgen (NASDAQ:AMGN) and raises the price target from $253 to $256.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 5:27 pm